Database: Medicines Registry (Sweden): Difference between revisions
No edit summary |
m (Update categories.) |
||
| Line 145: | Line 145: | ||
<span style="display:none">hasDataAccessCosts::Data has access costs</span> | <span style="display:none">hasDataAccessCosts::Data has access costs</span> | ||
<span style="display:none">isDatabase</span> | <span style="display:none">isDatabase</span> | ||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | |||
<span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span> | |||
<span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span> | |||
<span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span> | |||
<span style="display:none">hasCancerType::C40-C41: Bone cancers</span> | |||
<span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span> | |||
<span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span> | |||
<span style="display:none">hasCancerType::C50: Breast cancer</span> | |||
<span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span> | |||
<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span> | |||
<span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span> | |||
<span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span> | |||
<span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span> | |||
<span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span> | |||
<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> | |||
<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span> | |||
<span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span> | |||
<span style="display:none">hasCancerType::D10-D36: Benign tumour</span> | |||
<span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span> | |||
<span style="display:none">hasCancerType::unknown</span> | |||
Revision as of 11:17, 6 December 2025
Go back to Sweden page
Type of database: registry.
Primary purpose: The objective of the pharmaceutical registry is to enhance patient safety within the pharmaceutical industry.
Sponsor, manager or home institution: Socialstyrelsen.
Type of information: cross-sectional. age, sex, place of residence, medication use, number of drugs, number of patients.
Data Dictionary: Medicines Registry.
Available type of information: shipments, medication use and ATC codes for all ages, drug groups for children 0-17 children; filtered by year, divided by age, monthly data divided by region, drug groups, ATC codes, regions, sex, measure (number of patients), year and month.
Source of information: The pharmaceutical register exclusively obtains data from the E-health authority, which requires all pharmaceutical trades to report their sales data. When a prescribed medication is dispensed, pharmacies must also furnish supplementary information to the E-health authority. The E-health authority, in turn, forwards information regarding prescription-based shipments to the National Board of Health and Welfare.
Data level: patient level.
Available data level: national level and regional level.
Number of records: About 100 million per year.
Date range: 2005 onwards.
Cancer areas of interest: C00-D48: All neoplasms. Click here to learn more.
Data access: partially publicly available: Click here to access. Instructions to request data for restricted content: click here to learn more. Data can be downloaded in the formats CSV, XLSX. Data has access costs.
Contact information: Click here to learn more.
